<?xml version="1.0" encoding="UTF-8"?>
<svg height="813.2" width="537.4" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.61,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.39,0.5,0.5,0.28,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.67,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25" y="44.8" x="315.6,321.4,327.2,333.5,338.8,342.0,344.4,348.6,353.3,358.1,361.7,366.5,371.2,373.9,376.3,381.1,385.8,390.6,395.3,398.5,403.2,408.0,411.1,415.9,420.6,425.3,430.1,433.3,438.1,442.8,447.6,452.3,454.7,459.5,461.9,465.0,469.8,474.5,480.8,483.2,488.0,492.8,497.5,502.3,505.4,510.2,514.9,519.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EXCLI Journal 2017;16:1103-1113 â€“ ISSN 1611-2156 </text>
  <text svgx:width="0.61,0.44,0.44,0.44,0.28,0.44,0.44,0.5" y="55.7" x="217.3,223.1,227.3,231.5,235.7,238.4,242.6,246.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Received</text>
  <text svgx:width="0.28" y="55.7" x="251.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.44,0.5,0.28,0.44,0.5" y="55.7" x="254.2,256.6,260.8,265.5,270.3,274.5,276.9,281.7,286.4,288.8,291.2,295.9,300.7,305.4,310.2,312.6,315.0,319.7,323.9,328.1,332.4,337.1,339.8,344.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> June 26, 2017, accepted</text>
  <text svgx:width="0.28" y="55.7" x="348.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5" y="55.7" x="351.2,353.6,359.4,364.2,368.9,373.7,377.4,380.0,382.4,387.2,391.9,394.3,396.7,401.4,406.2,410.9,415.7,418.0,420.4,425.2,429.9,434.7,437.3,440.0,443.6,448.4,452.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 17, 2017, published</text>
  <text svgx:width="0.28" y="55.7" x="457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" y="55.7" x="460.0,462.4,468.2,473.0,477.7,482.5,486.1,488.8,491.2,495.9,500.7,503.1,505.5,510.2,514.9,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 29, 2017 </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.25" y="803.2" x="285.7,291.7,297.7,303.7,309.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1103 </text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.28,0.56,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.44,0.33,0.25" y="98.2" x="249.2,260.1,266.3,270.2,277.2,281.1,288.9,295.9,299.8,303.3,310.3,316.5,321.2,325.1,331.3,335.2,341.4,346.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:14.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Original article: </text>
  <text svgx:width="0.72,0.72,0.67,0.39,0.33,0.39,0.72,0.61,0.67,0.72,0.94,0.94,0.72,0.67,0.78,0.72,0.72,0.25,0.67,0.61,0.61,0.67,0.72,0.67,0.25,0.72,0.72,0.72,0.25,0.94,0.67,0.72,0.78,0.72,0.72,0.39,0.56,0.94,0.25,0.78,0.61,0.25,0.72,0.72,0.67,0.39,0.78,0.72,0.25,0.78,0.61,0.25" y="126.2" x="71.7,81.8,91.9,101.2,106.7,111.3,116.8,126.9,135.4,144.7,154.8,168.0,181.3,191.4,200.7,211.6,221.7,231.8,235.3,244.7,253.2,261.8,271.1,281.2,290.5,294.1,304.2,314.3,324.4,327.9,341.1,350.5,360.6,371.5,381.6,391.7,397.1,404.9,418.1,421.6,432.5,441.1,444.5,454.7,464.8,474.1,479.6,490.5,500.6,504.0,514.9,523.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:14.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ANTI-INFLAMMATORY EFFECT AND MECHANISM OF ACTION OF </text>
  <text transform="matrix(1.0,0.0,0.0,1.0,0.0,0.0)" rotateDegrees="0" matrix="[13.98,0.0,4.7813,13.98,138.6,699.6803]" svgx:width="0.67,0.39,0.72,0.72,0.67,0.72,0.72,0.25,0.67,0.72,0.72,0.67,0.78,0.72,0.78,0.72,0.72,0.72,0.61,0.72,0.25,0.67,0.56,0.56,0.67,0.72,0.67,0.39,0.72,0.67,0.25,0.78,0.39,0.67,0.25,0.39,0.72,0.25,0.25" y="142.3" x="138.6,147.9,153.4,163.5,173.6,182.9,193.0,203.1,206.6,215.9,226.0,236.1,245.4,256.3,266.4,277.3,287.4,297.5,307.6,316.1,326.3,329.8,339.2,347.0,354.8,364.1,374.2,383.5,389.0,399.1,408.4,411.9,422.8,428.3,437.6,441.1,446.5,456.6,460.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:14.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LINDERA ERYTHROCARPA ESSENTIAL OIL IN </text>
  <text svgx:width="0.67,0.39,0.61,0.78,0.61,0.78,0.67,0.72,0.56,0.72,0.72,0.72,0.78,0.72,0.72,0.39,0.72,0.67,0.33,0.56,0.67,0.39,0.94,0.72,0.67,0.72,0.67,0.67,0.72,0.25,0.72,0.72,1.0,0.5,0.5,0.5,0.25,0.5,0.25,0.72,0.67,0.67,0.67,0.56,0.25" y="158.4" x="105.4,114.7,120.1,128.7,139.6,148.1,159.0,168.4,178.5,186.2,196.3,206.4,216.5,227.4,237.5,247.6,253.1,263.2,272.5,277.2,285.0,294.3,299.8,313.0,323.1,332.5,342.6,351.9,361.2,371.3,374.8,385.0,395.1,409.0,416.0,423.0,430.0,433.6,440.6,444.1,454.2,463.5,472.8,482.2,489.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:14.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LIPOPOLYSACCHARIDE-STIMULATED RAW264.7 CELLS </text>
  <text svgx:width="0.72,0.44,0.5,0.5,0.5,0.33,0.39,0.5,0.5,0.5,0.25,0.72,0.5" y="186.2" x="70.9,79.6,84.9,90.9,96.9,102.9,106.9,111.6,117.6,123.6,129.6,132.6,141.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Yeong-Jong Ko</text>
  <text svgx:width="0.44,0.25,0.5" y="181.7" x="147.2,150.8,152.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a,1</text>
  <text svgx:width="0.25,0.25,0.72,0.28,0.5,0.5,0.44,0.44,0.25,0.72,0.5,0.5" y="186.2" x="156.8,159.8,162.8,171.5,174.8,180.8,186.8,192.2,197.5,200.5,209.2,215.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Ginnae Ahn</text>
  <text svgx:width="0.5,0.25,0.5" y="181.7" x="221.2,225.2,227.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">b,1</text>
  <text svgx:width="0.25,0.25,0.72,0.5,0.5,0.5,0.5,0.33,0.89,0.28,0.5,0.25,0.72,0.44,0.78" y="186.2" x="231.2,234.2,237.2,245.8,251.9,257.9,263.9,269.9,273.9,284.5,287.9,293.9,296.9,305.4,310.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Young-Min Ham</text>
  <text svgx:width="0.44" y="181.7" x="320.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a</text>
  <text svgx:width="0.25,0.25,0.56,0.44,0.5,0.5,0.33,0.89,0.5,0.44,0.5,0.25,0.56,0.5,0.5,0.5" y="186.2" x="323.6,326.6,329.6,336.3,341.6,347.7,353.7,357.7,368.3,374.3,379.7,385.7,388.7,395.3,401.3,407.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Sang-Mock Song</text>
  <text svgx:width="0.44" y="181.7" x="413.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a</text>
  <text svgx:width="0.25,0.25,0.61,0.5,0.5,0.33,0.72,0.28,0.25,0.72,0.5" y="186.2" x="416.9,419.9,422.9,430.2,436.2,442.2,446.2,454.9,458.2,461.2,469.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Eun-Yi Ko</text>
  <text svgx:width="0.44" y="181.7" x="475.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">c</text>
  <text svgx:width="0.25,0.25,0.25" y="186.2" x="479.4,482.4,485.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, </text>
  <text svgx:width="0.56,0.5,0.33,0.72,0.5,0.44,0.5,0.5,0.25,0.67,0.5,0.5" y="200.0" x="70.9,77.6,83.6,87.6,96.2,102.2,107.6,113.6,119.6,122.6,130.6,136.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Su-Hyeon Cho</text>
  <text svgx:width="0.44" y="195.5" x="142.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">c</text>
  <text svgx:width="0.25,0.25,0.94,0.44,0.5,0.5,0.33,0.39,0.5,0.5,0.5,0.25,0.72,0.5,0.5,0.5" y="200.0" x="146.1,149.1,152.1,163.4,168.7,174.7,180.7,184.7,189.4,195.4,201.4,207.4,210.4,219.1,225.1,231.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Weon-Jong Yoon</text>
  <text svgx:width="0.44,0.25,0.5" y="195.5" x="237.1,240.6,242.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a,*</text>
  <text svgx:width="0.25,0.25,0.72,0.28,0.28,0.33,0.72,0.44,0.78,0.25,0.72,0.28,0.78" y="200.0" x="246.6,249.7,252.7,261.3,264.7,268.0,272.0,280.6,286.0,295.2,298.2,306.9,310.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, Kil-Nam Kim</text>
  <text svgx:width="0.44,0.25,0.5,0.25,0.5,0.25" y="195.5" x="319.6,323.2,325.2,329.1,331.1,335.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">c,d,* </text>
  <text svgx:width="0.44,0.25" y="223.1" x="70.9,74.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">a </text>
  <text svgx:width="0.39,0.44,0.28,0.5,0.25,0.67,0.28,0.5,0.5,0.28,0.5,0.44,0.33,0.39,0.28,0.28,0.5,0.25,0.67,0.44,0.39,0.44,0.44,0.33,0.44,0.5,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.33,0.39,0.67,0.67,0.33,0.33,0.25,0.25,0.39,0.44,0.28,0.5,0.25,0.61,0.44,0.44,0.5,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.33,0.39,0.61,0.56,0.33,0.25,0.25,0.39,0.44,0.28,0.5,0.25,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.25" y="227.6" x="85.1,89.8,95.1,98.5,104.5,107.5,115.5,118.8,124.8,130.8,134.1,140.1,145.5,149.5,154.1,157.5,160.8,166.8,169.8,177.8,183.1,187.8,193.1,198.4,202.4,207.8,213.8,216.8,220.8,226.8,231.4,234.8,238.1,241.4,247.4,250.8,256.1,259.1,263.1,267.8,275.8,283.7,287.7,291.7,294.7,297.7,302.4,307.7,311.1,317.1,320.0,327.4,332.7,338.0,344.0,350.0,356.0,362.0,367.4,371.4,377.4,380.4,384.4,389.0,396.4,403.0,407.0,410.0,413.0,417.7,423.0,426.4,432.4,435.3,441.3,447.3,453.3,457.3,463.3,469.4,475.4,478.4,481.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Jeju Biodiversity Research Institute (JBRI), Jeju Technopark (JTP), Jeju 699-943, </text>
  <text svgx:width="0.67,0.44,0.5,0.5,0.5,0.28,0.28,0.44,0.25,0.5,0.33,0.25,0.72,0.5,0.33,0.44,0.44,0.25" y="241.4" x="85.1,93.1,98.5,104.5,110.5,116.5,119.8,123.2,128.5,131.5,137.5,141.5,144.5,153.2,159.2,163.2,168.5,173.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Republic of Korea </text>
  <text svgx:width="0.5,0.25" y="250.7" x="70.9,74.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">b </text>
  <text svgx:width="0.72,0.44,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.89,0.44,0.33,0.28,0.5,0.44,0.25,0.67,0.28,0.5,0.33,0.56,0.5,0.5,0.5,0.25,0.56,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.25,0.67,0.5,0.5,0.5,0.5,0.44,0.78,0.25,0.72,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.72,0.5,0.28,0.5,0.44,0.33,0.39,0.28,0.28,0.5,0.25,0.25,0.72,0.44,0.5,0.39,0.5,0.25,0.5,0.5,0.5,0.33,0.5,0.5,0.25,0.25" y="255.2" x="85.1,93.8,99.1,105.1,110.5,114.5,117.8,127.1,132.4,138.4,141.8,144.8,150.8,154.8,157.8,168.4,173.8,177.8,181.1,187.1,192.4,195.4,203.5,206.8,212.8,216.8,223.5,229.5,235.5,241.5,244.5,251.2,256.5,259.8,265.2,271.2,276.5,281.8,286.5,289.5,292.5,300.5,306.5,312.5,318.5,324.5,329.9,339.1,342.1,350.8,356.1,359.5,362.8,368.8,374.8,380.1,383.5,386.5,395.1,401.1,404.5,410.5,415.8,419.8,424.5,427.8,431.2,437.2,440.2,443.2,451.8,457.2,463.2,467.8,473.8,476.9,482.9,488.9,494.9,498.9,504.9,510.9,513.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Department of Marine Bio-Food Sciences, Chonnam National University, Yeosu 550-74, </text>
  <text svgx:width="0.67,0.44,0.5,0.5,0.5,0.28,0.28,0.44,0.25,0.72,0.5,0.33,0.44,0.44,0.25" y="269.0" x="85.1,93.1,98.5,104.5,110.4,116.4,119.8,123.1,128.4,131.4,140.1,146.1,150.1,155.4,160.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Republic Korea </text>
  <text svgx:width="0.44,0.25" y="278.3" x="70.9,74.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">c </text>
  <text svgx:width="0.67,0.5,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.25,0.72,0.5,0.33,0.44,0.44,0.25,0.67,0.44,0.39,0.28,0.44,0.25,0.56,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.33,0.72,0.67,0.56,0.33,0.33,0.25,0.25,0.67,0.5,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.67,0.44,0.5,0.5,0.5,0.28,0.28,0.44,0.25" y="282.8" x="85.1,93.1,99.1,105.2,111.2,116.5,122.5,127.8,133.8,139.8,142.8,150.8,156.2,162.2,165.5,170.8,174.8,177.8,180.8,189.5,195.5,199.5,204.8,210.2,213.2,221.2,226.5,231.2,234.5,239.8,242.8,249.5,254.8,258.2,263.5,269.5,274.8,280.2,283.2,287.2,293.1,297.8,301.1,304.4,307.8,313.8,317.1,322.4,325.4,329.4,338.1,346.1,352.8,356.8,360.8,363.8,366.8,374.8,380.8,386.8,392.8,398.1,404.1,409.5,415.5,421.5,424.5,430.5,436.5,442.5,446.5,452.5,458.5,464.5,467.5,470.5,478.5,483.8,489.8,495.8,501.8,505.1,508.5,513.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chuncheon Center, Korea Basic Science Institute (KBSI), Chuncheon 200-701, Republic </text>
  <text svgx:width="0.5,0.33,0.25,0.72,0.5,0.33,0.44,0.44,0.25" y="296.6" x="85.1,91.1,95.1,98.1,106.8,112.8,116.8,122.1,127.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of Korea </text>
  <text svgx:width="0.5,0.25" y="305.9" x="70.9,74.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">d </text>
  <text svgx:width="0.72,0.44,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.89,0.44,0.33,0.28,0.5,0.44,0.25,0.67,0.28,0.5,0.28,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.5,0.44,0.33,0.39,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.56,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.61,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.44,0.28,0.44,0.5,0.5,0.25" y="310.4" x="85.1,93.8,99.1,105.1,110.5,114.5,117.8,127.1,132.4,138.4,141.7,144.7,150.7,154.7,157.7,168.4,173.7,177.7,181.1,187.1,192.4,195.4,203.4,206.8,212.8,216.1,221.4,226.8,232.8,238.8,244.8,248.1,254.1,260.1,266.1,269.1,272.1,280.8,286.8,290.2,296.1,301.4,305.4,310.1,313.4,316.8,322.8,325.8,331.7,335.7,338.7,345.4,350.7,354.1,359.4,365.4,370.7,376.0,379.0,384.4,390.4,396.4,399.4,406.7,412.0,417.3,423.3,429.3,435.3,438.7,444.7,450.7,456.7,459.7,462.7,471.3,476.6,482.0,485.3,490.6,496.6,502.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Department of Marine Biotechnology, University of Science and Technology, Daejeon </text>
  <text svgx:width="0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.67,0.44,0.5,0.5,0.5,0.28,0.28,0.44,0.25,0.5,0.33,0.25,0.72,0.5,0.33,0.44,0.44,0.25" y="324.2" x="85.1,91.1,97.1,103.1,107.1,113.1,119.1,125.1,128.1,131.1,139.1,144.5,150.5,156.5,162.5,165.8,169.1,174.4,177.4,183.4,187.4,190.4,199.1,205.1,209.1,214.4,219.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">305-350, Republic of Korea </text>
  <text svgx:width="0.5,0.25" y="347.3" x="70.9,74.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1 </text>
  <text svgx:width="0.61,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.28,0.5,0.5,0.33,0.39,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.72,0.5,0.33,0.5,0.25,0.25" y="351.8" x="85.1,92.5,98.5,103.8,108.5,113.8,116.8,122.2,128.2,131.5,137.5,143.5,147.5,152.2,155.1,160.5,166.5,172.5,175.8,179.8,183.2,189.2,195.1,198.5,203.8,209.8,212.7,218.1,224.1,230.1,235.4,238.8,242.1,248.1,251.1,254.5,260.5,263.4,266.8,272.8,276.1,280.8,283.8,292.5,298.5,302.5,308.5,311.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">These authors contributed equally to this work. </text>
  <text svgx:width="0.5,0.25,0.55,0.67,0.5,0.33,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.33,0.39,0.28,0.25,0.25,0.55,0.61,0.44,0.28,0.25,0.28,0.25,0.56,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.33,0.78,0.44,0.28,0.28,0.28,0.25" y="379.4" x="70.9,76.9,79.9,85.2,93.2,99.2,103.2,107.2,112.6,117.2,123.3,129.3,135.3,141.3,144.6,150.6,156.6,159.6,164.9,170.9,174.3,180.3,186.3,190.3,194.9,198.3,201.3,204.3,212.8,220.1,225.4,228.8,231.8,235.1,238.1,244.9,250.9,256.8,260.9,266.9,272.8,276.8,282.8,288.8,294.8,298.8,304.8,310.8,316.8,322.9,325.9,328.8,336.2,340.2,349.4,354.8,358.1,361.4,364.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">* Corresponding authors: Tel.: +82-33-815-4607, E-mail: </text>
  <text svgx:width="0.5,0.5,0.5,0.28,0.78,0.92,0.5,0.5,0.39,0.28,0.25,0.33,0.44,0.25,0.5,0.33" y="379.4" x="367.7,373.7,379.7,385.7,389.1,398.4,409.4,415.4,421.4,426.1,429.4,432.4,436.4,441.7,444.7,450.7" style="fill:rgb(0,0,255);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">knkim@kbsi.re.kr</text>
  <text svgx:width="0.25,0.33,0.72,0.25,0.72,0.25,0.25,0.72,0.28,0.78,0.33,0.25" y="379.4" x="454.7,457.7,461.7,470.4,473.4,482.0,485.0,488.0,496.7,500.0,509.3,513.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (K.N. Kim) </text>
  <text svgx:width="0.25,0.55,0.25,0.55,0.61,0.44,0.28,0.25,0.28,0.25,0.56,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.33,0.78,0.44,0.28,0.28,0.28,0.25" y="393.2" x="70.9,73.9,85.2,88.2,212.7,220.0,225.4,228.7,231.7,235.1,238.1,244.9,250.9,256.8,260.8,266.8,272.8,276.8,282.8,288.8,294.8,298.8,304.8,310.8,316.8,322.9,325.9,328.8,336.1,340.2,349.4,354.7,358.1,361.4,364.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> Tel.: +82-64-720-2840, E-mail: </text>
  <text svgx:width="0.5,0.5,0.28,0.5,0.28,0.92,0.28,0.44,0.28,0.5,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.33" y="393.2" x="367.7,373.7,379.7,383.1,389.1,392.4,403.5,406.8,412.1,415.5,421.5,424.8,430.8,433.8,439.8,443.8,446.8,452.8" style="fill:rgb(0,0,255);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">yyjkl@jejutp.or.kr</text>
  <text svgx:width="0.25,0.33,0.94,0.25,0.39,0.25,0.25,0.72,0.5,0.5,0.5,0.33,0.25" y="393.2" x="456.8,459.8,463.8,475.0,478.0,482.7,485.7,488.7,497.4,503.4,509.4,515.4,519.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (W.J. Yoon) </text>
  <text svgx:width="0.56,0.28,0.28,0.56,0.28,0.28,0.28,0.56,0.5,0.28,0.56,0.56,0.22,0.28,0.56,0.33,0.56,0.28,0.56,0.56,0.28,0.56,0.56,0.56,0.56,0.56,0.28,0.56,0.5,0.5,0.22,0.22,0.56,0.56,0.56,0.56,0.33,0.56,0.56,0.56,0.28" y="417.2" x="70.9,75.4,77.6,79.8,84.2,86.5,88.7,90.9,95.3,99.3,101.6,106.1,110.5,112.3,114.5,118.9,121.6,126.0,128.3,132.7,137.2,139.4,143.8,148.3,152.7,157.2,161.6,163.8,168.3,172.3,176.3,178.1,179.8,184.3,188.7,193.1,197.6,200.2,204.7,209.1,213.6" style="fill:rgb(0,0,255);font-family:ArialMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">http://dx.doi.org/10.17179/excli2017-596 </text>
  <text svgx:width="0.61,0.56,0.22,0.5,0.28,0.22,0.5,0.28,0.56,0.56,0.28,0.78,0.56,0.56,0.56,0.28,0.67,0.5,0.5,0.56,0.5,0.5,0.28,0.56,0.33,0.28,0.22,0.5,0.22,0.56,0.28,0.56,0.22,0.5,0.28,0.33,0.22,0.56,0.56,0.28,0.56,0.56,0.28,0.56,0.56,0.56,0.56,0.33,0.28,0.28,0.56,0.56,0.28,0.28,0.56,0.33,0.83,0.5,0.28,0.56,0.28,0.28,0.28,0.56,0.56,0.28,0.72,0.33,0.56,0.56,0.28,0.22,0.5,0.56,0.28,0.72,0.56,0.83,0.83,0.56,0.56,0.5,0.28,0.67,0.28,0.28,0.33,0.22,0.56,0.56,0.28,0.22,0.56,0.56,0.28,0.56,0.22,0.5,0.56,0.56,0.5,0.56,0.28,0.28" y="440.2" x="70.9,75.8,80.2,82.0,86.0,88.2,90.0,94.0,96.2,100.7,105.1,107.3,113.6,118.0,122.4,126.9,129.2,134.5,138.5,142.5,146.9,150.9,154.9,157.1,161.6,164.2,166.5,168.2,172.2,174.0,178.5,180.7,185.1,186.9,190.9,193.1,195.8,197.6,202.0,206.4,208.7,213.1,217.6,219.8,224.2,228.7,233.1,237.5,240.2,242.5,244.8,249.2,253.7,255.9,258.1,262.6,265.2,271.9,275.9,278.1,282.5,284.8,287.0,289.2,293.7,298.1,300.4,306.2,308.8,313.3,317.7,320.0,321.7,325.7,330.2,332.4,338.2,342.6,349.3,355.9,360.4,364.9,368.9,371.1,376.5,378.7,380.9,383.6,385.3,389.8,394.2,396.5,398.2,402.7,407.1,409.4,413.8,415.6,419.6,424.0,428.5,432.5,436.9,439.1" style="fill:rgb(0,0,0);font-family:ArialMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">This is an Open Access article distributed under the terms of the Creative Commons Attribution License </text>
  <text svgx:width="0.33" y="449.3" x="70.9" style="fill:rgb(0,0,0);font-family:ArialMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(</text>
  <text svgx:width="0.56,0.28,0.28,0.56,0.28,0.28,0.28,0.5,0.33,0.56,0.56,0.28,0.22,0.5,0.56,0.5,0.56,0.83,0.83,0.56,0.56,0.5,0.28,0.56,0.33,0.56,0.28,0.22,0.22,0.5,0.56,0.56,0.5,0.56,0.5,0.28,0.56,0.5,0.28,0.56,0.28,0.56,0.28" y="449.3" x="73.6,78.0,80.2,82.5,86.9,89.1,91.4,93.6,97.6,100.3,104.7,109.1,111.4,113.2,117.2,121.6,125.6,130.1,136.7,143.4,147.9,152.3,156.3,158.5,163.0,165.6,170.1,172.3,174.1,175.9,179.9,184.3,188.8,192.8,197.2,201.2,203.4,207.9,211.8,214.1,218.5,220.7,225.2" style="fill:rgb(0,0,255);font-family:ArialMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">http://creativecommons.org/licenses/by/4.0/</text>
  <text svgx:width="0.33,0.28" y="449.3" x="227.4,230.0" style="fill:rgb(0,0,0);font-family:ArialMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">).</text>
  <text svgx:width="0.72,0.67,0.56,0.67,0.72,0.72,0.72,0.67,0.25" y="476.2" x="265.0,273.6,281.6,288.3,296.3,305.0,313.6,322.3,330.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ABSTRACT </text>
  <text svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25" y="493.9" x="70.9,77.1,82.1,86.5,89.0,93.5,96.2,103.9,106.4,111.4,114.7,117.2,120.0,125.0,127.8,131.7,134.1,138.0,140.8,145.8,150.8,155.8,158.3,165.5,170.0,173.9,176.3,179.0,184.1,186.5,189.3,194.3,199.4,203.7,207.7,210.4,213.2,218.2,222.7,225.5,229.9,232.4,235.1,240.1,244.6,247.0,251.4,256.4,260.9,268.6,271.3,275.8,280.2,283.0,285.5,289.9,295.0,300.0,303.9,306.6,309.4,312.1,317.2,321.6,326.6,329.4,333.3,335.8,340.8,344.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The aim of this study was to investigate the chemical constituents of </text>
  <text svgx:width="0.56,0.28,0.5,0.5,0.44,0.39,0.5,0.25,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.44,0.5,0.39,0.5,0.5" y="493.9" x="346.6,352.1,354.9,359.9,364.9,369.3,373.2,378.3,380.7,385.2,389.1,393.6,396.3,401.3,405.2,410.2,414.6,419.6,423.5,428.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera erythrocarpa</text>
  <text svgx:width="0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.33,0.61,0.61,0.72,0.33,0.25,0.5,0.5,0.25" y="493.9" x="433.5,436.0,440.4,444.3,448.2,452.6,457.6,460.4,463.2,467.6,470.4,472.8,477.9,480.7,483.4,485.9,489.2,495.3,501.4,508.7,512.0,514.4,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> essential oil (LEO) by </text>
  <text svgx:width="0.5,0.44,0.39,0.25,0.44,0.5,0.33,0.5,0.78,0.44,0.28,0.5,0.5,0.33,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.39,0.39,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.44,0.28,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="505.4" x="70.9,75.9,80.4,84.3,86.5,90.9,96.0,99.3,104.3,112.0,116.4,119.2,124.2,129.2,132.6,137.1,142.0,147.1,152.0,155.4,163.1,167.5,171.5,175.4,177.6,181.5,186.5,190.9,195.4,198.2,201.5,206.5,214.2,218.7,221.4,224.8,229.8,232.0,236.5,241.5,246.5,248.7,253.1,258.2,262.6,265.4,270.4,274.9,277.6,282.1,284.3,287.0,292.0,296.5,299.3,302.6,304.8,307.5,312.6,317.6,320.3,325.3,328.1,330.8,335.9,339.2,344.2,346.4,350.8,354.2,357.5,362.0,366.4,369.1,371.3,376.4,381.4,383.6,386.3,391.4,395.8,398.1,402.4,407.4,412.4,415.8,420.3,424.1,428.0,430.8,435.8,440.8,443.0,448.0,451.3,453.5,458.5,461.8,466.8,470.2,472.9,477.9,481.3,484.0,488.4,496.2,503.9,508.4,511.1,516.2,519.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">gas chromatography-mass spectrometry and evaluate their inhibitory effect on the expression of pro-inflammatory </text>
  <text svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.28,0.5,0.25,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.25,0.33,0.61,0.56,0.56,0.33,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.56,0.28,0.33,0.28,0.44,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.25,0.44,0.44,0.44,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.25,0.83,0.25,0.5,0.33,0.25" y="517.0" x="70.9,78.7,83.2,88.2,90.9,95.4,98.2,103.2,106.5,110.4,112.8,115.5,120.6,123.0,125.7,128.5,133.5,138.5,143.5,148.5,151.3,156.3,160.2,164.7,169.1,173.6,178.6,183.0,186.4,189.1,194.1,198.5,200.9,204.2,210.3,215.9,221.5,224.8,228.1,231.9,234.7,237.5,245.2,250.2,253.0,257.4,260.2,264.7,269.7,272.1,278.7,286.0,295.4,300.4,305.4,310.4,312.9,317.9,320.3,324.7,329.2,332.0,334.7,338.6,341.1,343.5,349.1,351.8,355.2,357.9,362.4,366.8,371.8,374.2,378.7,383.6,391.3,396.4,401.4,406.4,411.4,416.4,420.3,422.7,425.1,429.6,434.0,438.5,443.5,448.5,453.5,456.2,459.0,464.0,469.0,471.3,474.7,479.7,483.0,485.3,490.3,495.3,497.8,502.8,505.4,513.7,516.1,521.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mediators in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Fifteen compounds, accounting for 63.7 % of </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.61,0.72,0.25,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.5,0.5,0.5,0.5,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.5,0.25,0.83,0.33,0.25,0.25,0.55,0.44,0.44,0.33,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.44,0.5,0.44,0.25" y="528.4" x="70.9,73.7,78.7,83.1,85.7,88.6,93.0,98.1,105.8,110.8,115.8,119.7,122.5,125.3,128.0,133.1,138.1,140.6,143.5,148.5,151.8,154.3,157.2,163.3,169.4,176.7,179.1,181.6,184.5,191.8,196.2,199.5,203.9,206.4,209.4,212.1,217.2,221.6,226.6,229.4,232.2,235.5,238.2,242.7,247.7,250.2,252.7,255.6,261.7,266.8,271.2,273.7,276.7,284.3,288.8,291.5,296.6,299.1,302.0,306.4,311.4,319.1,324.2,329.2,334.2,339.2,344.2,348.1,350.6,353.5,360.7,365.1,368.4,372.9,375.4,378.3,383.3,387.7,391.1,396.1,398.9,401.6,406.6,411.6,414.4,416.9,419.8,423.1,428.1,433.2,435.6,440.6,445.6,448.2,456.5,459.8,462.3,464.8,467.7,472.2,476.6,479.9,484.9,489.9,494.9,500.0,504.9,507.7,510.5,514.9,519.9,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the composition of LEO, were identified. The main compounds were nerolidol (18.73 %), caryophyllene </text>
  <text svgx:width="0.33,0.5,0.5,0.25,0.5,0.5,0.25,0.83,0.33,0.25,0.25,0.52,0.33,0.5,0.5,0.78,0.5,0.28,0.44,0.5,0.44,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.83,0.33,0.25,0.25,0.5,0.44,0.33,0.78,0.44,0.44,0.33,0.44,0.5,0.44,0.33,0.72,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.83,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.52,0.33,0.5,0.28,0.5,0.44,0.5,0.44,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.83,0.33,0.25,0.25,0.61,0.61,0.72,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25" y="539.9" x="70.9,74.3,79.3,84.3,86.8,91.8,96.8,99.3,107.6,111.0,113.5,115.9,121.1,124.4,129.4,134.4,142.1,147.1,149.9,154.3,159.4,163.8,166.2,169.6,174.6,177.1,182.0,187.1,189.5,197.9,201.3,203.8,206.1,211.1,215.6,219.0,226.6,231.1,235.5,238.9,243.3,248.4,252.8,256.2,263.4,265.7,269.1,274.1,276.6,281.6,286.7,289.2,297.5,300.8,303.3,305.7,310.1,315.2,320.2,322.5,327.7,331.0,336.1,338.8,343.9,348.3,353.3,357.8,360.1,363.4,368.5,370.9,376.0,381.0,383.5,391.8,395.1,397.6,400.0,406.1,412.2,419.4,421.8,425.7,428.4,433.5,438.5,441.3,444.6,447.3,451.8,456.2,461.2,464.0,466.8,471.7,474.1,476.9,481.9,487.0,489.7,494.8,497.5,500.3,504.7,509.8,512.2,514.9,520.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(14.41 %), Î±-humulene (7.73 %), germacrene-D (4.82 %), and Î±-pinene (4.47 %). LEO significantly inhibited the </text>
  <text svgx:width="0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.5,0.5,0.28,0.5,0.44,0.25,0.33,0.72,0.72,0.33,0.25,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.33,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.25,0.44,0.5,0.5,0.25" y="551.5" x="70.9,75.4,80.4,85.4,88.8,93.2,97.1,101.0,103.7,108.8,113.8,116.4,121.5,124.8,127.5,130.2,135.3,140.2,145.3,149.7,152.5,157.5,160.3,164.8,167.4,172.4,175.2,177.9,181.3,184.1,188.5,191.2,196.2,201.3,204.0,209.0,213.5,216.2,219.5,226.7,233.9,237.3,240.0,243.9,248.8,253.8,256.6,261.6,266.1,270.0,274.4,277.1,281.5,286.5,291.5,294.2,298.7,303.7,308.1,310.9,315.9,320.9,325.9,330.9,335.9,340.3,345.4,349.8,353.7,358.2,361.5,366.5,369.0,371.7,376.2,381.2,386.2,388.9,392.8,397.7,402.8,406.7,411.1,416.1,421.1,425.5,430.5,433.3,436.0,441.0,444.3,449.3,454.3,459.3,463.8,466.6,469.3,474.3,479.4,482.0,487.0,490.4,493.0,500.3,507.5,510.1,514.5,519.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">expression of inducible nitric oxide (NO) synthase and cyclooxygenase-2, and subsequent production of NO and </text>
  <text svgx:width="0.5,0.33,0.5,0.39,0.28,0.44,0.5,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.61" y="562.9" x="70.9,76.0,79.3,84.3,88.2,91.0,95.4,100.5,103.2,107.6,112.6,117.7,120.4,125.4,128.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">prostaglandin E</text>
  <text svgx:width="0.5" y="563.9" x="134.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:6.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.33,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.28,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.61,0.56,0.56,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25" y="562.9" x="137.6,140.1,143.1,146.4,151.4,154.4,158.8,163.9,168.9,171.7,174.5,177.2,182.2,187.3,189.7,192.7,195.5,198.3,201.3,204.6,209.0,214.0,219.1,223.5,227.9,232.9,235.9,238.6,243.7,248.1,251.1,254.4,258.8,261.6,266.0,270.5,274.3,278.8,281.7,286.8,290.1,293.0,298.0,301.3,306.4,309.7,312.4,317.5,320.8,323.5,327.9,335.7,343.5,347.9,350.7,355.7,359.0,364.0,367.0,371.4,376.4,379.1,384.2,389.2,392.0,397.0,401.4,405.3,408.3,411.1,416.1,419.1,425.2,430.7,436.3,439.6,444.0,448.4,451.2,453.9,459.0,463.4,466.2,470.6,475.6,478.6,485.2,492.4,501.9,506.9,511.9,516.9,519.4,524.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">. In addition, it reduced the release of pro-inflammatory cytokines in LPS-activated RAW264.7 </text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.61,0.61,0.72,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.33" y="574.4" x="70.9,75.4,79.8,82.6,85.4,89.3,91.8,94.4,100.5,105.5,110.0,112.6,120.3,125.3,128.1,132.6,137.0,142.0,144.8,149.2,152.6,155.2,162.9,167.3,171.8,176.8,181.2,186.2,189.0,192.9,200.6,203.2,208.2,213.3,218.3,222.6,226.0,228.8,233.8,236.5,241.6,246.6,249.1,251.9,256.9,261.4,264.0,268.4,271.7,275.1,279.5,284.0,286.7,289.3,294.3,297.6,300.2,306.3,312.4,319.6,322.3,329.5,334.0,337.8,340.4,344.9,348.7,352.6,357.6,362.1,364.8,369.2,372.0,376.4,381.4,384.0,391.2,394.0,396.8,401.8,404.4,407.2,412.2,417.2,420.0,425.0,427.8,430.6,433.3,438.3,443.3,445.9,450.9,454.2,456.9,459.6,464.6,469.1,471.7,476.7,481.7,486.7,490.6,495.6,500.6,505.6,508.9,513.9,516.7,521.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cells. The molecular mechanism underlying the effect of LEO was associated with inhibition of the phosphoryla-</text>
  <text svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.28,0.28,0.5,0.5,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.33,0.89,0.72,0.56,0.72,0.33,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.61,0.61,0.72,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25" y="586.0" x="70.9,73.7,76.4,81.5,86.5,88.9,93.9,97.2,99.6,107.3,110.1,112.8,117.9,122.9,127.4,132.4,135.7,140.2,144.7,147.4,150.2,155.2,159.7,162.5,166.8,171.9,174.3,179.3,182.6,187.5,190.3,194.8,197.5,202.5,204.9,210.0,212.7,217.8,222.2,226.1,230.6,232.9,236.3,245.1,252.4,257.9,265.1,268.5,271.0,273.3,278.9,283.9,287.3,290.0,295.1,299.4,302.7,310.4,315.4,318.8,323.3,325.8,328.2,334.3,340.5,347.7,350.1,352.9,357.9,362.8,365.6,370.6,373.4,376.1,380.6,385.6,388.0,394.1,399.7,405.3,408.6,411.4,416.4,421.3,426.4,430.8,435.3,440.3,442.7,447.7,452.7,457.7,461.6,466.5,471.5,476.6,479.9,484.8,487.6,492.1,494.8,497.6,502.6,507.6,510.0,514.5,519.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tion of mitogen-activated protein kinase (MAPK). Furthermore, LEO inhibited LPS-induced phosphorylation and </text>
  <text svgx:width="0.5,0.44,0.5,0.33,0.44,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.5,0.44,0.25,0.67,0.33,0.52,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.28,0.39,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.72,0.56,0.33,0.33" y="597.4" x="70.9,76.0,80.4,85.4,88.8,93.2,98.2,102.7,105.4,108.2,113.2,118.2,120.6,125.6,128.9,131.3,134.0,139.1,144.1,146.9,151.9,154.7,157.4,162.4,165.8,168.1,173.2,176.5,178.9,183.9,188.3,193.3,198.3,202.7,205.1,211.8,215.1,220.3,222.8,225.2,232.4,237.4,240.2,244.6,249.6,252.0,254.8,258.7,261.1,264.4,268.8,273.8,278.9,281.6,284.9,289.4,294.4,296.8,300.1,305.1,308.4,310.7,313.5,318.5,323.0,325.4,329.8,334.2,337.0,339.8,344.8,349.3,352.0,354.8,359.8,364.8,367.2,372.2,375.6,378.0,380.7,385.7,390.2,392.5,397.5,402.5,407.6,410.0,414.4,419.4,424.4,426.8,431.8,436.8,441.8,444.2,449.2,454.2,458.6,461.4,465.8,470.3,473.6,475.9,479.3,483.7,488.1,490.9,495.9,499.3,501.6,505.0,512.2,517.7,521.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">degradation of inhibitor of kappa B-Î±, which is required for the activation of the p50 and p65 nuclear factor (NF)-</text>
  <text svgx:width="0.5,0.67,0.25,0.39,0.5,0.5,0.5,0.5,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.61,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.28,0.5,0.44,0.28,0.25,0.61,0.61,0.72,0.25,0.44,0.5,0.44,0.33,0.28,0.44,0.5,0.25,0.28,0.28,0.39,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25" y="608.9" x="70.9,76.0,82.6,85.2,89.0,94.1,99.1,104.1,109.1,111.9,114.7,118.6,121.1,123.8,128.9,131.3,138.0,145.2,154.7,159.7,164.7,169.7,172.2,177.2,179.8,184.2,188.6,191.3,194.1,198.0,200.5,203.0,209.1,213.6,218.6,223.0,228.0,230.5,233.3,238.3,243.4,247.8,250.5,255.5,260.0,263.3,265.8,268.3,271.1,276.1,280.6,284.5,288.9,291.4,296.4,300.8,303.6,308.1,310.4,314.3,319.4,324.4,329.4,333.8,337.7,340.5,343.0,345.8,350.8,355.2,358.0,360.5,366.6,372.7,379.9,382.5,386.9,391.9,396.4,399.7,402.4,406.9,411.9,414.4,417.2,420.0,423.8,426.4,430.8,435.8,438.6,441.4,444.7,447.5,452.5,455.9,458.6,463.1,470.9,478.6,483.0,485.8,490.8,494.1,499.1,501.7,506.1,509.4,512.8,517.2,521.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ÎºB subunits in RAW264.7 cells. Taken together, these data suggest that LEO exerted its anti-inflammatory effect </text>
  <text svgx:width="0.5,0.5,0.25,0.5,0.5,0.72,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.44,0.5,0.5,0.25" y="620.5" x="70.9,76.0,80.9,83.8,88.8,93.7,101.0,106.0,109.3,113.7,118.7,123.8,126.5,131.0,133.7,136.5,141.5,146.6,149.4,155.5,161.1,166.6,169.9,172.6,177.6,182.7,187.7,192.1,196.5,201.6,204.3,209.4,212.7,217.6,222.7,227.7,232.1,234.9,237.7,242.7,247.7,250.5,255.5,258.8,261.6,266.6,269.9,274.9,278.3,281.0,286.0,289.3,292.1,296.5,304.3,312.1,316.5,319.3,324.4,327.7,332.7,335.5,343.2,347.6,352.6,355.4,359.8,362.6,367.7,371.0,374.9,377.7,380.5,385.5,388.8,393.8,398.8,403.8,408.8,411.6,414.4,419.4,423.8,426.6,429.4,434.4,439.5,442.2,447.2,450.0,452.8,455.5,460.6,465.5,468.4,473.3,476.7,479.4,486.6,492.2,495.6,500.6,507.2,510.1,514.5,519.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">by downregulating LPS-induced production of pro-inflammatory mediators through the inhibition of NF-ÎºB and </text>
  <text svgx:width="0.89,0.72,0.56,0.72,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25" y="631.9" x="70.9,79.8,87.1,92.6,99.8,102.4,106.2,109.0,114.0,119.0,123.5,126.2,129.0,134.0,139.0,141.5,144.3,149.4,151.9,158.5,165.7,175.2,180.1,185.1,190.1,192.6,197.7,200.2,204.6,209.0,211.8,214.6,218.4,220.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MAPK signaling in RAW264.7 cells. </text>
  <text svgx:width="0.78,0.44,0.5,0.72,0.5,0.44,0.56,0.39,0.33" y="657.2" x="70.9,78.7,83.2,88.2,95.4,100.4,104.8,110.4,114.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Keywords:</text>
  <text svgx:width="0.56,0.28,0.5,0.5,0.44,0.39,0.5,0.25,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.44,0.5,0.39,0.5,0.5" y="657.2" x="120.1,125.7,128.4,133.4,138.5,142.8,146.7,151.7,154.2,158.7,162.6,167.1,169.8,174.9,178.7,183.7,188.1,193.1,197.1,202.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera erythrocarpa</text>
  <text svgx:width="0.25,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.25,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.25,0.89,0.72,0.56,0.72,0.25" y="657.2" x="207.1,209.5,212.1,216.5,221.5,224.3,227.1,230.4,233.1,238.2,241.5,244.3,248.7,256.5,264.2,268.7,271.5,276.5,279.8,284.8,287.3,289.8,294.3,298.1,302.0,306.4,311.5,314.2,317.0,321.4,324.2,326.7,331.8,334.5,337.3,339.8,342.3,349.5,355.1,358.4,363.4,370.1,372.6,375.1,384.0,391.2,396.8,404.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, anti-inflammatory, essential oil, NF-ÎºB, MAPK </text>
  <text svgx:width="0.39,0.72,0.67,0.72,0.78,0.72,0.72,0.72,0.67,0.39,0.78,0.72,0.25" y="705.2" x="132.1,136.7,145.4,153.4,162.1,171.4,180.1,188.7,197.4,205.4,210.0,219.4,228.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">INTRODUCTION </text>
  <text svgx:width="0.56,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" y="724.9" x="88.8,95.5,99.5,105.5,108.8,114.8,120.8,126.8,132.2,138.2,140.6,144.0,150.0,154.0,157.3,162.6,172.0,181.3,186.6,190.0,193.3,199.3,205.3,207.8,211.1,215.8,218.3,221.6,227.6,233.6,239.6,243.0,249.0,254.3,260.3,262.8,266.1,272.1,274.6,277.9,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Prolonged inflammation is involved in the </text>
  <text svgx:width="0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.33" y="738.7" x="70.9,76.9,82.3,85.6,91.6,97.6,103.6,108.9,114.9,120.3,124.9,128.3,133.0,136.5,142.5,146.5,150.0,155.4,158.9,164.9,170.2,174.2,177.6,182.9,186.3,192.3,195.8,201.8,205.8,209.3,215.3,218.7,223.4,228.7,234.0,238.7,244.0,248.7,251.7,255.2,258.6,264.6,269.9,273.3,279.3,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pathogenesis of a variety of diseases, includ-</text>
  <text svgx:width="0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.28,0.78,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.33,0.28,0.5,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.28,0.5,0.44,0.33,0.5,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25" y="752.5" x="70.9,74.3,80.3,86.3,89.3,98.8,104.8,110.8,114.1,123.4,129.4,135.4,140.8,144.8,150.8,153.8,163.3,167.3,170.6,176.6,180.6,186.6,191.3,194.7,199.3,202.3,205.3,214.9,220.2,223.5,229.5,234.9,238.9,244.9,249.5,254.9,258.2,263.5,267.5,273.5,278.2,281.5,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ing pulmonary fibrosis, atherosclerosis, </text>
  <text svgx:width="0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.25,0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.33" y="705.1" x="306.1,311.5,317.5,321.5,327.5,333.5,336.8,342.2,344.8,350.8,356.1,362.1,367.3,370.7,374.0,377.4,380.7,385.4,388.4,391.0,395.0,401.0,406.3,412.4,421.6,426.9,430.3,436.3,439.6,445.7,448.2,453.6,457.5,460.9,466.9,470.9,474.2,477.5,480.9,485.5,488.5,491.1,496.4,502.4,508.5,511.0,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">chronic hepatitis, rheumatoid arthritis, and in-</text>
  <text svgx:width="0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.33,0.67,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="718.9" x="306.1,310.1,313.5,318.8,328.1,337.5,342.8,346.1,352.1,356.1,362.1,365.1,369.9,375.9,379.9,385.2,388.6,394.6,397.6,402.4,408.4,411.7,416.4,421.7,427.0,431.7,437.0,441.7,444.7,449.5,453.5,461.5,467.5,473.5,479.5,485.5,488.5,493.3,498.6,502.0,505.0,509.8,515.1,518.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">flammatory brain diseases (Chung et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.44,0.5,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="732.7" x="306.1,312.1,318.1,324.1,330.1,334.1,337.1,339.9,343.9,349.9,353.9,357.3,362.6,371.9,381.3,386.6,389.9,393.3,399.3,405.3,408.1,411.4,416.1,418.9,424.2,429.6,435.6,440.2,445.6,451.6,454.4,460.4,466.4,469.2,475.2,479.2,485.2,489.2,492.5,498.5,502.5,505.8,511.2,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007). Inflammation is caused by pro-inflam-</text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="746.5" x="306.1,315.4,320.7,324.1,330.1,334.1,340.1,343.2,352.4,357.8,363.8,367.1,372.5,375.8,381.8,385.9,390.5,393.5,396.5,399.8,405.8,411.1,414.4,420.4,426.4,429.7,435.7,441.7,444.7,450.7,456.7,460.1,466.1,469.1,475.1,479.0,485.0,489.0,492.4,498.4,502.4,505.7,511.0,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">matory mediators, including both pro-inflam-</text>
 </g>
</svg>
